The treatment of multiple myeloma (MM) has undergone significant developments in recent years. The availability of the novel agents thalidomide, bortezomib, and lenalidomide has expanded treatment options and has improved the outcome of patients with MM. Following the introduction of these agents in...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!